These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 15124861

  • 1. Elimination of activated but not resting primary human CD4+ and CD8+ T cells by Fas ligand (FasL/CD95L)-expressing Killer-dendritic cells.
    Hoves S, Krause SW, Herfarth H, Halbritter D, Zhang HG, Mountz JD, Schölmerich J, Fleck M.
    Immunobiology; 2004; 208(5):463-75. PubMed ID: 15124861
    [Abstract] [Full Text] [Related]

  • 2. Mature but not immature Fas ligand (CD95L)-transduced human monocyte-derived dendritic cells are protected from Fas-mediated apoptosis and can be used as killer APC.
    Hoves S, Krause SW, Halbritter D, Zhang HG, Mountz JD, Schölmerich J, Fleck M.
    J Immunol; 2003 Jun 01; 170(11):5406-13. PubMed ID: 12759415
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Alloantigen specific deletion of primary human T cells by Fas ligand (CD95L)-transduced monocyte-derived killer-dendritic cells.
    Schütz C, Hoves S, Halbritter D, Zhang HG, Mountz JD, Fleck M.
    Immunology; 2011 May 01; 133(1):115-22. PubMed ID: 21342185
    [Abstract] [Full Text] [Related]

  • 8. A subclass of dendritic cells regulates the response of naive CD8 T cells by limiting their IL-2 production.
    Kronin V, Winkel K, Süss G, Kelso A, Heath W, Kirberg J, von Boehmer H, Shortman K.
    J Immunol; 1996 Nov 01; 157(9):3819-27. PubMed ID: 8892611
    [Abstract] [Full Text] [Related]

  • 9. Dendritic cells recruit T cell exosomes via exosomal LFA-1 leading to inhibition of CD8+ CTL responses through downregulation of peptide/MHC class I and Fas ligand-mediated cytotoxicity.
    Xie Y, Zhang H, Li W, Deng Y, Munegowda MA, Chibbar R, Qureshi M, Xiang J.
    J Immunol; 2010 Nov 01; 185(9):5268-78. PubMed ID: 20881190
    [Abstract] [Full Text] [Related]

  • 10. Dendritic cells undergo rapid apoptosis in vitro during antigen-specific interaction with CD4+ T cells.
    Matsue H, Edelbaum D, Hartmann AC, Morita A, Bergstresser PR, Yagita H, Okumura K, Takashima A.
    J Immunol; 1999 May 01; 162(9):5287-98. PubMed ID: 10228004
    [Abstract] [Full Text] [Related]

  • 11. Effective treatment of established mouse collagen-induced arthritis by systemic administration of dendritic cells genetically modified to express FasL.
    Kim SH, Kim S, Oligino TJ, Robbins PD.
    Mol Ther; 2002 Nov 01; 6(5):584-90. PubMed ID: 12409256
    [Abstract] [Full Text] [Related]

  • 12. Switching from a restricted to an effective CD4 T cell response by activating CD8+ murine dendritic cells with a Toll-like receptor 9 ligand.
    Rizzitelli A, Vremec D, Villadangos JA, Mavaddat N, Wright MD, Shortman K.
    Eur J Immunol; 2005 Nov 01; 35(11):3209-20. PubMed ID: 16224811
    [Abstract] [Full Text] [Related]

  • 13. Increased lymphocyte apoptosis in Fas ligand transgenic mice.
    Cheng J, Liu C, Yang P, Zhou T, Mountz JD.
    J Immunol; 1997 Jul 15; 159(2):674-84. PubMed ID: 9218582
    [Abstract] [Full Text] [Related]

  • 14. The Fas death pathway controls coordinated expansions of type 1 CD8 and type 2 CD4 T cells in Trypanosoma cruzi infection.
    Guillermo LV, Silva EM, Ribeiro-Gomes FL, De Meis J, Pereira WF, Yagita H, DosReis GA, Lopes MF.
    J Leukoc Biol; 2007 Apr 15; 81(4):942-51. PubMed ID: 17261545
    [Abstract] [Full Text] [Related]

  • 15. Targeting dendritic cells with CD44 monoclonal antibodies selectively inhibits the proliferation of naive CD4+ T-helper cells by induction of FAS-independent T-cell apoptosis.
    Termeer C, Averbeck M, Hara H, Eibel H, Herrlich P, Sleeman J, Simon JC.
    Immunology; 2003 May 15; 109(1):32-40. PubMed ID: 12709015
    [Abstract] [Full Text] [Related]

  • 16. Changes in sensitivity of peripheral lymphocytes of autoimmune gld mice to FasL-mediated apoptosis reveal a mechanism for the preferential deletion of CD4-CD8-B220+ T cells.
    Xiao S, Zhang X, Mann KK, Jodo S, Li L, Jarjour WN, Marshak-Rothstein A, Sherr DH, Ju ST.
    Int Immunol; 2004 May 15; 16(5):759-66. PubMed ID: 15096479
    [Abstract] [Full Text] [Related]

  • 17. Differential expression of Fas and Fas ligand in acute and chronic graft-versus-host disease: up-regulation of Fas and Fas ligand requires CD8+ T cell activation and IFN-gamma production.
    Shustov A, Nguyen P, Finkelman F, Elkon KB, Via CS.
    J Immunol; 1998 Sep 15; 161(6):2848-55. PubMed ID: 9743345
    [Abstract] [Full Text] [Related]

  • 18. Induction of antitumor immunity with Fas/APO-1 ligand (CD95L)-transfected neuroblastoma neuro-2a cells.
    Shimizu M, Fontana A, Takeda Y, Yagita H, Yoshimoto T, Matsuzawa A.
    J Immunol; 1999 Jun 15; 162(12):7350-7. PubMed ID: 10358186
    [Abstract] [Full Text] [Related]

  • 19. Monocytes express Fas ligand upon CD4 cross-linking and induce CD4+ T cells apoptosis: a possible mechanism of bystander cell death in HIV infection.
    Oyaizu N, Adachi Y, Hashimoto F, McCloskey TW, Hosaka N, Kayagaki N, Yagita H, Pahwa S.
    J Immunol; 1997 Mar 01; 158(5):2456-63. PubMed ID: 9036997
    [Abstract] [Full Text] [Related]

  • 20. A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis.
    Süss G, Shortman K.
    J Exp Med; 1996 Apr 01; 183(4):1789-96. PubMed ID: 8666935
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.